# Denali Therapeutics Inc.: Form DEF 14A, filed Apr 21, 2026

- Company: [Denali Therapeutics Inc.](/companies/dnli.md) (CIK 1714899)
- Form: DEF 14A
- Filed: 2026-04-21
- Accepted by EDGAR: Apr 21, 2026, 16:31 ET
- Period: 2025-12-31
- Accession: 0001714899-26-000054
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/dnli-20260421.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1714899/000171489926000054/dnli-20260421.htm

Filed Apr 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001714899-26-000054. Last ingested by Listed: Nov 3, 2026, 19:01 ET. No prices; not investment advice.
